DD55956A - - Google Patents

Info

Publication number
DD55956A
DD55956A DD55956DA DD55956A DD 55956 A DD55956 A DD 55956A DD 55956D A DD55956D A DD 55956DA DD 55956 A DD55956 A DD 55956A
Authority
DD
German Democratic Republic
Application number
Publication of DD55956A publication Critical patent/DD55956A/xx

Links

DD55956D DD55956A (en)

Publications (1)

Publication Number Publication Date
DD55956A true DD55956A (en)

Family

ID=251922

Family Applications (1)

Application Number Title Priority Date Filing Date
DD55956D DD55956A (en)

Country Status (1)

Country Link
DD (1) DD55956A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302132A1 (en) * 1987-01-27 1989-02-08 Deutsche Hydrierwerke GmbH Rodleben Process and device for the preparation of 5-methyl-7-diethyl amino-s-triazolo[1,5-a] pyrimidine
WO2002002563A2 (en) * 2000-06-30 2002-01-10 Wyeth Substituted-triazolopyrimidines as anticancer agents
WO2004108136A1 (en) * 2003-06-04 2004-12-16 Vernalis (Cambridge) Limited Triazolo `1 , 5-a!pyrimidines and their use in medicine
WO2005025315A1 (en) * 2003-09-12 2005-03-24 Basf Aktiengesellschaft 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302132A1 (en) * 1987-01-27 1989-02-08 Deutsche Hydrierwerke GmbH Rodleben Process and device for the preparation of 5-methyl-7-diethyl amino-s-triazolo[1,5-a] pyrimidine
WO2002002563A2 (en) * 2000-06-30 2002-01-10 Wyeth Substituted-triazolopyrimidines as anticancer agents
WO2002002563A3 (en) * 2000-06-30 2003-01-03 Wyeth Corp Substituted-triazolopyrimidines as anticancer agents
AU2001273062B2 (en) * 2000-06-30 2005-11-24 Wyeth Substituted-triazolopyrimidines as anticancer agents
WO2004108136A1 (en) * 2003-06-04 2004-12-16 Vernalis (Cambridge) Limited Triazolo `1 , 5-a!pyrimidines and their use in medicine
WO2005025315A1 (en) * 2003-09-12 2005-03-24 Basf Aktiengesellschaft 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests
EA010091B1 (en) * 2003-09-12 2008-06-30 Басф Акциенгезельшафт 6-halogeno-[1,2,4]triazolo[1.5-a]pyrrimidines for combating animal pests
AU2004271715B2 (en) * 2003-09-12 2010-08-26 Basf Aktiengesellschaft 6-halogeno-(1,2,4)triazolo(1,5-a)pyrimidines for combating animal pests
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases

Similar Documents

Publication Publication Date Title
US7329663B2 (en) Substituted-triazolopyrimidines as anticancer agents
AU2001273062A1 (en) Substituted-triazolopyrimidines as anticancer agents
AU2006318310B2 (en) Heterocyclic CETP inhibitors
US20070275961A1 (en) Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine
AU2004271715B2 (en) 6-halogeno-(1,2,4)triazolo(1,5-a)pyrimidines for combating animal pests
ATE547394T1 (en) N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPANE-1- AMINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLERosis AND CARDIOVASCULAR DISEASES
EP0302132B1 (en) Process and device for the preparation of 5-methyl-7-diethyl amino-s-triazolo[1,5-a] pyrimidine
DD55956A (en)